Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 12/02/2009 - (DGNews)
    Obesity Leading Risk Factor of Left Atrial Enlargement During Aging - (DGNews)
    TopAbstracts in Hypertension 11/25/2009 - (DGNews)
    Team-Based Care Involving a Pharmacist Improves Blood Pressure Control - (DGNews)
    Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study - (BMJ)

    News archive

     Recent webcasts/CME - Hypertension
    • State of the Art in Pulmonary Arterial Hypertension
    • Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment
      Treating Coronary Artery Disease in Vulnerable Adults
      Thrombotic Thrombocytopenic Purpura: The Masquerader

      Webcasts/CME archive

       Recent cases - Hypertension
        A Woman with Swollen Fingers and New-Onset Hypertension and Renal Failure
        Hypertension
        Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
        Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
        Giant Right Coronary Artery Aneurysm: Case Report and Literature Review

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Eplerenone As Effective As Amlodipine For Systolic Hypertension, Widened Pulse Pressure

        A DGReview of :"Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension"
        Hypertension

        04/28/2003
        By James Adams


        Eplerenone, a selective aldosterone blocker, is as effective as amlodipine, a calcium antagonist, in improving systolic blood pressure, pulse pressure and pulse wave velocity in older patients with systolic hypertension and widened pulse pressure.

        In patients with microalbuminuria, eplerenone is more effective than is amlodipine at reducing the urinary albumin/creatinine ratio, investigators report.

        The investigators, from multiple institutions including the University of Connecticut School of Medicine in Farmington, United States, compared eplerenone and amlodipine in 269 patients with systolic hypertension and widened pulse pressure. Patients were aged 50 years or older.

        They were randomly assigned to receive either 50 to 200 milligrams eplerenone or 2.5 to 10 milligrams amlodipine daily in a double blind titration to effect design. Clinic blood pressure and pulse pressure were assessed in all patients, and ambulatory blood pressure, vascular compliance and urinary albumin secretion were assessed in a subset of patients.

        Results showed that systolic blood pressure was reduced by similar amounts in both treatment groups after 24 weeks of therapy. The reduction was 20.5 ± 1.1 mm Hg in the eplerenone group and 20.1 ± 1.1 in the amlodipine group.

        For diastolic blood pressure, amlodipine was somewhat more effective with a reduction of 6.9 mm Hg compared with a reduction of 4.5 mm Hg with eplerenone. Reductions in pulse pressure from baseline were also similar between the two groups, as were changes in pulse wave velocity.

        Eplerenone reduced the urinary albumin/creatinine ratio by 52% in patients with microalbuminuria. Amlodipine treatment resulted in a 10% reduction.
        Hypertension 2003;[epub ahead of print]. "Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send